Company Filing History:
1 out of 28 
1 out of 1,744 
Years Active: 2016
Title: Le Hoa Mai: Innovator in Antibody Research
Introduction
Le Hoa Mai is a prominent inventor based in Orvault, France. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on antibodies.
Latest Patents
Le Hoa Mai holds a patent for "Antibodies directed against the alpha chain of IL7 receptor—their use for the preparation of drug candidates." This invention focuses on antibodies that target CD127, the alpha chain of the interleukin-7 receptor, specifically the human IL-7 receptor alpha. The antibodies exhibit cytotoxic activity against CD127 positive cells and are intended for use in treating various conditions, including transplant rejection, autoimmune diseases, allergic diseases, lymphoma, and cancer associated with CD127 positive cells. He has 1 patent in this area.
Career Highlights
Throughout his career, Le Hoa Mai has worked with notable organizations such as Ose Immunotherapeutics and the National Institute of Health and Medical Research. His work has been pivotal in advancing therapeutic strategies in immunology.
Collaborations
Le Hoa Mai has collaborated with esteemed colleagues, including Sophie Brouard and Caroline Mary, contributing to the advancement of research in his field.
Conclusion
Le Hoa Mai's innovative work in antibody research has the potential to significantly impact the treatment of various diseases. His contributions continue to shape the future of immunotherapy.